Phoenix, Arizona – (Newsfile Corp. – May 27, 2021) – The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops and commercializes innovative platform technologies to solve challenging environmental problems such as PFAS pollution, advanced water and wastewater treatment, industrial odor and VOC control, air quality control and infection control. BioLargo president and CEO, Dennis P. Calvert, joined Stock Day presenter Everett Jolly for an interview.
Jolly began the interview by commenting on the company’s latest announcements, including a recent press release detailing the elimination of nearly all of the company’s convertible debt. “We have taken quite a bit of risks [three years ago]; we needed that capital and we did a great job of it. We have two advanced platform technologies that are now in a commercial stage, they are dramatic and they have a great future, ” said Calvert. a tribute to our great technology and to our people. “
“We really had to get that convertible debt out of the way,” Calvert continued, noting that the company’s debt peaked at $ 7.6 million in 2018. [but $50,000] of this convertible debt, which has continued to weigh on equities. So it is a great moment. “
Jolly then commented on the company’s recent earnings and growth. “I think we’re just scratching the surface,” Calvert said. “We have made some really important relationships. We have new technologies in our portfolio. We are incredibly active and dynamic in developing important commercial and revenue opportunities.”
“Can you give us an update on the company’s PFAS project?” Jolly asked. “It’s a very exciting opportunity,” said Calvert. “There is a mandate from Biden’s administration to clear this up. The great thing about this situation is that we got a bit of a head start before it got bigger and bigger in the market, which means we have the talent and technical solution. developed to be in commercial mode now. “
“We would like to be in the field within 60-120 days. [PFAS] is a pollution that must come out; it’s the environmental disaster of the decade, “he explained.” We just think this is such a huge opportunity. We are going to go through it from start to finish and prove it is a commercially viable, economical and environmentally friendly solution. Then we will partner with companies and spread it around the world. “
Calvert went on to address the potential customers for this industry, which likely include the military, municipal, and industrial customers. “Who serves those people? There are actually two classes: environmental engineering companies and specialized large companies dealing with water,” explains Calvert. “Both are real distributor and partner opportunities for us.”
“What are the outlook for your business for the next twelve months?” Jolly asked. “The hardest work has been done,” said Calvert. “We have never been more excited than today … we have funding that really provides the means to help us through this commercial divide,” he continued. “I think this is a time when investor enthusiasm is unprecedented and it will continue. So we are a company to keep an eye on.”
“You have to be careful because the evolution of this business is so dynamic that if you don’t look every six months, you only know about half the story,” said Calvert. “The hard work is done, the price is ours, let’s do the work and get it done.”
Follow the link to the podcast here to hear Dennis Calvert’s full interview: https://audioboom.com/posts/7875307-biolargo-blgo-discusses-elimination-of-convertible-debt-and-progress-on-commercialization-of-pf
About BioLargo, Inc.
BioLargo, Inc. (OTCQB: BLGO) invents, develops and commercializes innovative platform technologies to solve challenging environmental problems such as PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control and infection control. With over 13 years of extensive R&D, BioLargo holds a wide range of issued patents, maintains a robust pipeline of products and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire new technologies and develop them to maturity through our operating subsidiaries. With a strong emphasis on collaboration with academic, municipal and commercial organizations and associations, BioLargo has proven itself with more than 80 awarded grants and numerous pilot projects. We make money through direct sales, recurring service contracts, license agreements, strategic joint venture formation and / or the sale of the IP. Several of our technologies are commercially available and are developing as disruptors in their respective markets. See our website at www.BioLargo.com.
Dennis P. Calvert
President and CEO, BioLargo, Inc.
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, those regarding BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; expected income; and plans for future operations. These statements involve risks and uncertainties and actual results could differ materially from future results expressed or implied by the forward-looking statements. Risks and uncertainties include, but are not limited to: the effect of the COVID-19 pandemic on the company, bottom line, financial condition and stock price; the effect of regional economic conditions on the business of the business, including effects on purchasing decisions by consumers and businesses; the Company’s ability to compete in markets that are highly competitive and subject to rapid technological change; the Company’s ability to manage frequent product and service launches and transitions, including market delivery, and drive customer demand for new products, services and technological innovations on a timely basis; the dependence of the company on the performance of distributors of the company’s products. More information about these risks and other potential factors that could affect the Company’s operations and financial results is included in the Company’s filings with the SEC, including in the sections “ Risk Factors ” and “ Financial Condition Discussion and Analysis. and operating results by management ‘. of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The company undertakes no obligation to update any forward-looking statements or information that is effective as of their respective dates.
About the ‘Stock Day’ podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors and works with penny stock and OTC companies simultaneously, and provides transparency and clarification of undervalued, under-sold Micro-Cap stocks in the market. Stock Day offers companies tailor-made solutions for their news distribution in both national and international media channels. The Stock Day Podcast is the number one radio show of its kind in America.
Stock Day Media
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/85514